Navigation Links
Drug to Prevent the Onset of Arthritis

Arthritis is a common health problem worldwide. Both osteoarthritis and rheumatoid arthritis cause joint pain and //stiffness in patients. There is no cure for arthritis and no effective treatment to repair damaged cartilage.

A new study could help lead doctors towards a drug to prevent the onset of arthritis. The research pinpoints the molecular pathway and an enzyme that play a pivotal role in the onset of the condition. Researchers from Cardiff University conducted research to better understand the molecular pathway involved in the onset of arthritis.

Early research has shown activity levels of two enzymes, MMP-2 and MMP-9, are frequently increased in the cartilage of people suffering from osteoarthritis. Researchers also know, in patients with arthritis, the cartilage releases a substance called proteoglycan. Scientists cultured cartilage cells in vitro to study this pathway as osteoarthritis develops.

The researchers stimulated the cells with two molecules that activate the arthritis processes. This caused the increased release of proteoglycan and the production and activation of MMPs. Researchers then inhibited the enzyme PKR in the cells. This time they found no increase in the activation of MMPs and that the release of proteoglycan was significantly reduced.

Researchers say the results of this study imply that PKR is involved in the molecular pathways that are implicated in the progression of arthritis. They hope this understanding will help in the discovery of novel targets for arthritis drugs.


'"/>




Page: 1

Related medicine news :

1. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
2. Prevention is better than cure
3. Prevention of cataracts
4. Medications to Prevent Relapse to Cocaine Use
5. Estrogen Does Not Prevent Recurrent Strokes
6. Over-The-Counter Drugs May Prevent Alzheimers
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Alcoholism Drug Fails To Prevent Drinking Relapses
9. Preventing mental decline in the aged
10. Preventing white coat hypertension
11. Simple Stroke Prevention is Best
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug Prevent the Onset Arthritis

(Date:5/12/2008)...CHARLOTTE, N.C., May 12 /PRNewswire-FirstCall/ -- ...e provider focused on high acuity health care,serv... cardiovascular,disease, today announced that Art ...rrently Interim Chief Financial Officer, has been ...nt effective immediately., "In his new role, Art ...
(Date:5/12/2008)... Reports Record Quarterly Sales of over $2...FirstCall/ -- Medifast, Inc.,(NYSE: MED ) announc...eriod,ended March 31, 2008., Financial highligh... 25%;, -- Gross margins increased to 75.8% vs. 74...r Life experienced sales increase of 63% year-...
(Date:5/11/2008)...HUDSON, N.H., May 12 /PRNewswire/ -- Atrium Medica...g a voluntary and precautionary recall of,selected...cic Drainage,Catheters. Limited lots of Atrium hep...ufactured with heparin found to have been contamin... The patient risk associated,with the presence of ...
(Date:5/11/2008)...COVER: "The O Team" (p. 20). Senior White House Co... campaign team, looking at the presidential,candid...,re all getting,ready for the coming mud war with ...insist that the race will be about the big issues ...idates over Iraq and the economy.,They,re also rea...
Breaking Medicine News(10 mins):Health News:MedCath Names Parker to New Finance Post 2Health News:Medifast Announces First Quarter 2008 Financial Results 2Health News:Medifast Announces First Quarter 2008 Financial Results 3Health News:Medifast Announces First Quarter 2008 Financial Results 4Health News:Medifast Announces First Quarter 2008 Financial Results 5Health News:Medifast Announces First Quarter 2008 Financial Results 6Health News:Medifast Announces First Quarter 2008 Financial Results 7Health News:Medifast Announces First Quarter 2008 Financial Results 8Health News:Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 4Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 5
... that children in deep sleep awoke to recordings o...nd ordering them out of their bedrooms –although t...makes. Dr. Gary Smith, one of the co-authors of t...rmed previous research which showed that what work...
...eloped 40 more people in the Indian capital Tuesda...horities// stated that the situation did not warra...to curb this menace. Our hospitals are well equipp...here is no need to declare dengue as epidemic," sa...
...d close to 100,000 people affected by chikungunya,...f Minister V.S. Achuthanandan Tuesday blamed exper...e of the disease. "Experts are confusing us becaus... The government is doing its best to contain it. W...
...ng man and took out at a four-cm long pin from his...ch he had swallowed six months ago unknowingly.// ...ere surprised that he lived for six months with th...ain. The pin Najeeb had swallowed apparently gon...
Other Medicine News:Health News:Mummy’s Voice More Effective than Smoke Alarm 2Health News:Dengue Outbreak in the Capital is not an Epidemic: Government 2
(Date:5/7/2008)... Safety in Treating a Leading ...NTVILLE, New Jersey and TARRYTOWN, New York, May,8... Regeneron,Pharmaceuticals, Inc. (NASDAQ: REGN ) ...sed in the VIEW 2 trial, a second Phase 3 clinical...ap-Eye for the treatment of the,neovascular form o...
(Date:5/7/2008)...-- Shire plc (LSE: SHP,Nasdaq: SHPGY), the global...ced findings from a new data analysis that was con...ANA(TM) (methylphenidate transdermal,system) betwe...n Deficit,Hyperactivity Disorder (ADHD). The findi... an established safety profile and effectively con...
(Date:5/7/2008)...ric Association Annual Meeting, WASHINGTON, May 7...c.,(NYSE: FRX ) announced today that study result...y improved symptoms of depression as compared to,p...ents, aged 12-17, with,major depressive disorder (... 2008 Annual Meeting of the American Psychiatric A...
(Date:5/7/2008)...stCall/ -- New Phase 1,clinical trial results for ...ar Therapeutics (Nasdaq: NKTR ) this week at the ...in Tampa, Florida. In this multiple-dose Phase,1 s...oral bioavailability,with rapid absorption and an ...wn half-life of unPEGylated naloxone., NKTR-118 i...
Breaking Medicine Technology:Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 2Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 3Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 4Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 5Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 2Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 3Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 4Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 5Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents 6NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 2NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 3NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 4NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 5NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 6James B Hawkins Appointed to IRIDEX Board of Directors 3709 1James B Hawkins Appointed to IRIDEX Board of Directors 3709 2James B Hawkins Appointed to IRIDEX Board of Directors 3709 3The First Mega Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery 3707 1The First Mega Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery 3707 2The First Mega Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery 3707 3Alma Lasers Answers Lumenis Complaint 3705 1Alma Lasers Answers Lumenis Complaint 3705 2How to Beat the High Cost of Living 3703 1How to Beat the High Cost of Living 3703 2
CVMstat® provides leading edge information on hundreds of topics involving all aspects of cardiovascular medicine, including sections on diagnosis and management of peripheral arterial and venou
Unbound Surgery, published by Unbound Medicine is an innovative digital resource that combines evidence-based clinical content and leading edge technology. It offers comprehensive information that is
Sages™ is the handheld version of The Sages Manual, a reference for the fundamentals of Laparoscopy and GI Endoscopy. It is a classic manual from the world's most pioneering society of minimally
This electronic survival guide provides all the essential information that every surgery intern needs from Day 1 on the wards.
Medicine Products: